![David Nelles](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Nelles
Vorstandsvorsitzender bei U1 Bio, Inc.
Profil
David Nelles was the founder and had held the position of Chief Technology Officer at Locanabio, Inc. from 2016 to 2020.
He is currently the Chief Executive Officer & Director at U1 Bio, Inc. which is his current job.
Dr. Nelles founded Locanabio, Inc. in 2016.
Aktive Positionen von David Nelles
Unternehmen | Position | Beginn |
---|---|---|
U1 Bio, Inc.
![]() U1 Bio, Inc. Miscellaneous Commercial ServicesCommercial Services U1 Bio, Inc. provides biotechnology research and development services. The CEO of the American company is David Nelles. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von David Nelles
Unternehmen | Position | Ende |
---|---|---|
Locanabio, Inc.
![]() Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Gründer | 01.01.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Locanabio, Inc.
![]() Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Technology Services |
U1 Bio, Inc.
![]() U1 Bio, Inc. Miscellaneous Commercial ServicesCommercial Services U1 Bio, Inc. provides biotechnology research and development services. The CEO of the American company is David Nelles. | Commercial Services |